Thursday - April 25, 2024

Category Archives: Pharmaceuticals & Biotech

Primary Biliary Cholangitis Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

DelveInsight’s ‘Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of primary biliary cholangitis in the United States, EU4 (Germany, Spain, Italy, France) and the … Continue reading →

Alagille Syndrome Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

DelveInsight’s report titled “Alagille Syndrome Market Insights, Epidemiology, and Market Forecast—2032” comprehensively analyzes Alagille Syndrome. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Alagille Syndrome further segmented by gender and age. … Continue reading →

Alpha-1 Protease Inhibitor Deficiency Market to Exhibit Growth at a CAGR of X% by 2032, estimates DelveInsight

DelveInsight’s “Alpha-1 Protease Inhibitor Deficiency Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Alpha-1 Protease Inhibitor Deficiency, historical and forecasted epidemiology as well as the Alpha-1 Protease Inhibitor Deficiency market trends in the United States, EU5 (Germany, … Continue reading →

Acquired hemophilia A Market to Witness an Upsurge in Growth by 2032, Examines DelveInsight

DelveInsight’s “Acquired hemophilia A Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Acquired hemophilia A, historical and forecasted epidemiology as well as the Acquired hemophilia A market trends in the United States, EU5 (Germany, Spain, Italy, France, … Continue reading →

Biliary Atresia Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight

DelveInsight’s “Biliary Atresia Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of the Biliary Atresia, historical and forecasted epidemiology as well as the Biliary Atresia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the … Continue reading →

Cryopyrin-associated Periodic Syndromes Market is Expected to Showcase a Significant Growth at a CAGR of X% by 2032, as per DelveInsight

DelveInsight’s “Cryopyrin-associated Periodic Syndromes Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cryopyrin-associated Periodic Syndromes, historical and forecasted epidemiology as well as the Cryopyrin-associated Periodic Syndromes market trends in the United States, EU5 (Germany, Spain, … Continue reading →

Asthma Treatment Market Size, Share, Trends, Growth And Forecast To 2032

Asthma Treatment Market By Drug Class (Anti-inflammatory, Bronchodilators, Combination Therapy), By Product (Inhalers, Nebulizers), By Route of Administration (Oral, Inhaled, Others), By Treatment Type (Long-term Asthma Control Medications, Quick-relief (Rescue) Medications) – Growth, Share, Opportunities & Competitive Analysis, 2024 – … Continue reading →

Respiratory Syncytial Virus Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, and Key Companies involved by DelveInsight | GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, Merck

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Respiratory Syncytial Virus pipeline constitutes 50+ key companies continuously working towards developing 50+ Respiratory Syncytial Virus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →